We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
5.00 | 0.29% | 1,733.50 | 1,732.50 | 1,733.00 | 1,739.50 | 1,724.50 | 1,733.00 | 4,237,056 | 16:35:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.48 | 71.35B |
Date | Subject | Author | Discuss |
---|---|---|---|
25/9/2020 13:05 | Gsk virtually two runners in the Corona race, prefer those odds, to Astra who nearly fell at the first fence with their testing. | montyhedge | |
25/9/2020 12:48 | Not sure have to be 1st but if they get a working vaccine I agree it will give a boost.There will be multiple vaccines - some will work better with different groups(age, race etc) | watfordhornet | |
25/9/2020 12:39 | Ok on the positive front, weaker sterling, experts believe below 1.20 to the pound Will boost FTSE 100 dollar earners and of course GSK. Most importantly GSK have really two runners in the Corona race, first with Sanofi and the second with a chinese bio company providing tech to them.. If GSK first then of course over 2000p a share, in the meantime collect a dividend cheque every 13 weeks, yield 5.51%. | montyhedge | |
25/9/2020 11:48 | If FTSE 100 hits 5100 then of course everything down, might be a chance to pick up GSK 1375p | montyhedge | |
25/9/2020 11:45 | Coronavirus disruption in supplies, hit GSK before, perhaps that's what the market expects on second wave. If so shareprice going lower. | montyhedge | |
25/9/2020 11:38 | International markets are even more overpriced, IMO. | lovewinshatelosses | |
25/9/2020 10:04 | Ftse 100 is underpriced currently compared to other international markets. But that could turn fast if this is a bad winter. Don't forget Brexit "cliff edge" Remoaners whine about is 1st Jan!!! Double jeopardy. Plenty to go wrong that will mean current levels see UK market overpriced! Service industry - Retail,Restaurant, Cinema are ALL toast. | geckotheglorious | |
25/9/2020 07:58 | Why post you know article does not show. | montyhedge | |
25/9/2020 00:17 | read BUY thread latest post re a live covid-19 test that works within seconds costs pennies per test close to 100% accuracy Sir Patrick Vallance has £600,000 shareholding in firm contracted to develop vaccines Vaccine story see BUY thread | buywell3 | |
24/9/2020 21:33 | Spud, I said FTSE100, not FTSE all share index. Some good individual stocks around still, but many more with lots of issues. Either way, I have heard the bull case for what you are suggesting and I simply disagree. The fall out of COVID is still very much to be factored in, I believe. Anyway, we shall see. Lots of fun in the meantime with the presidential election, the many and haphazard approaches to handling covid on national levels across the globe, including furlough schemes that might yield the largest amount of zombie companies in our lifetime. Add in the money printing of late and I think my number may well appear too conservative. But time will tell. | lovewinshatelosses | |
24/9/2020 19:55 | Overpriced at 5500 lol! The UK is the most undervalued European Market currently!!Plucked & thin air spring to mind....spud | spud | |
24/9/2020 19:07 | FTSE 100 will still be overpriced at 5500. GSK is a buy at under £15 IMO, but in terms of short term trading this? No idea! Probably slightly more downside from here, if you forced me to make a call. | lovewinshatelosses | |
24/9/2020 17:10 | moderna and johnson and johnson will be first to market. Astra still hasnt got go ahead to restart from fda. Gsk and sanofi some way behind it would seem. | porsche1945 | |
24/9/2020 16:17 | FTSE 100 heading for 5750 and GSK 1410p. | montyhedge | |
24/9/2020 15:44 | All six COVID-19 vaccines in industrial manufacturing - HHS Secretary Azar Bloomberg reports that, according to Health and Human Services (HHS) Secretary Alex Azar, all six frontrunning COVID-19 vaccines are being produced at industrial scale. The companies have all previously announced production ramp-ups ahead of anticipated emergency use approvals aimed at being prepared for prompt widespread distribution. "Tad premature surely??" | geckotheglorious | |
24/9/2020 14:58 | I don't take vaccines because you do not get a list of possible side effects like you do with medication in tablet, liquid or gel form | wipo1 | |
24/9/2020 13:39 | Any publicity is good publicity would be my answer!spud | spud | |
24/9/2020 13:23 | Not hyping would be my answer. Sanofi are smart people. IMO there will be plenty of disappointments. The initial launch dates etc were nuts - how could politicians be so stupid? IMO at least one candidate will get through. | alphorn | |
24/9/2020 13:14 | Your right no mention of GSK vaccine at all, are GSK still in the race or left at the start. | montyhedge | |
24/9/2020 11:49 | Zero reference to GSK. spud | spud | |
24/9/2020 10:44 | A very good article from the FT (free to read) on vaccine progress. | alphorn | |
24/9/2020 10:31 | GSK were very lucky with Advair as the difficulties of duplicating the particle performance specification were such a high barrier that it kept generics at bay for years. Without this I think the first generics would have come to market easily 5 or 6 years ago. (And | rikky72 | |
24/9/2020 10:17 | Of course! (Licensed products excepted) | tradermichael | |
24/9/2020 10:15 | TM - are you suggesting a 'no generic' world??? | alphorn |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions